Somewhere inside one of your upper back teeth, a canal barely wider than a strand of hair may be branching off and hiding. It is called the MB2 canal, and it is one of the most stubbornly missed structures in all of dentistry. Miss it during a root canal, and the tooth can keep quietly failing for years. That blind spot is what makes AI MB2 canal detection so tempting — and researchers are now asking a pointed question: can a machine find the canal that experienced dentists so often overlook?
The 30-Second Version
- The MB2 canal hides in roughly 69–93% of upper first molars, yet it is routinely missed — a leading cause of failed root canals and retreatment.
- A 2026 scoping review in the International Dental Journal asked whether AI is ready to catch it on 3D scans. From 1,218 records, only 5 studies qualified.
- In the lab the AI looked strong: F1 scores up to 0.93, with sensitivity and accuracy above 0.80 in all five.
- The honest catch: every model was stuck at the prototype stage (readiness level 4 of 9), and none had been externally validated. Impressive — but not clinic-ready.
It sounds like exactly the problem AI was built for: a subtle, easily overlooked pattern buried in hundreds of grayscale image slices. But AI MB2 canal detection is only as trustworthy as the evidence behind it — so Amal Shaiban and colleagues, publishing in the International Dental Journal in 2026, did something more careful than another accuracy contest. They mapped the entire field, then measured not how clever the models are, but how close any of them is to a real dental chair. Their guiding question was blunt: are these tools actually ready?
The study, in one glance
This was a scoping review — a structured survey of the published evidence, following PRISMA guidelines. The team searched PubMed, Embase, and Scopus from inception to February 2026, screened 1,218 records, and found just five studies that met their criteria: four retrospective and one on extracted teeth, all using cone-beam CT (CBCT) scans. Then, crucially, they scored each study on the Technology Readiness Level – Implementation Science (TRL-IS) scale, a 9-step ladder that runs from “basic idea” (level 1) to “routine real-world use” (level 9).
What AI MB2 canal detection actually gets right
On the numbers alone, the models are genuinely impressive. A two-step system combining a convolutional neural network with a U-Net (Mansour and colleagues) reached an F1 score of 0.93, an accuracy of 0.87, and a recall of 1.00 — meaning it flagged every MB2 canal it was tested on. A YOLOv5x model (Duman and colleagues) hit 0.92 sensitivity and a mean average precision of 0.88, and a 3D U-Net (Albitar and colleagues) posted 0.90 accuracy with perfect specificity. Across all five studies, sensitivity and accuracy landed above 0.80 — near-expert, and in some tasks better than the human eye scanning slice after slice of a CBCT volume. For a canal this small and this often missed, that is exactly the kind of tireless second look that should help.
So why can’t your dentist use it yet?
Here is where the review earns its keep. When Shaiban’s team scored those five studies on the readiness ladder, every single one stopped at level 4 — “prototyping.” Not one reached level 5, which simply requires that a model be tested on data it has never seen, from a different clinic. Levels 6 through 9 — proving it works in real clinical conditions, then actually deploying it — were untouched. In other words, all five systems proved they can perform on their own home dataset, and nothing more.
⚠ Prototype is not the same as product
Those eye-catching scores come almost entirely from retrospective, mostly single-center datasets. Using the QUADAS-2 quality tool, the reviewers rated all five studies as having “some concerns” about bias — around how patients were selected, whether the AI was tested blind to the answer key, and how thresholds were set. High marks on your own test do not mean high marks on someone else’s.
It’s the difference between a car that aces the closed test track and one that is actually road-legal in traffic.
The evidence base is thin in a second way. Five studies is a very small foundation, and the “ground truth” they trained against was usually a panel of expert radiologists — whose own MB2 calls vary, because that is precisely why the canal is hard. Adherence to AI reporting standards (the TRIPOD+AI checklist) averaged just 51%, and reporting on data preprocessing, blinding, and missing data scored 0%. When the recipe isn’t fully written down, no one else can reliably reproduce the dish.
Who is responsible if the AI misses the canal?
This is the question that turns a research demo into a clinical liability. If an AI tool flags — or fails to flag — an MB2 canal and the root canal later fails, who is accountable: the dentist, the software maker, the clinic? The review flags this squarely. Before any of these tools belongs in routine practice, it needs to clear regulatory approval as software acting as a medical device, with clear rules on data privacy and responsibility. Until then, the sensible framing is the one the authors themselves land on: a decision-support adjunct, never a standalone diagnosis.
Does the MB2 canal look the same in every mouth?
It does not — and that is a real equity problem. The prevalence and shape of the MB2 canal vary with ancestry, age, and sex, yet every model in this review was built on retrospective data from a single center. Tellingly, not one study reported anything about health inequalities across sociodemographic groups: on that item of the reporting checklist, adherence was 0%. An algorithm trained on one population’s molars may quietly underperform on another’s, and right now there is no evidence either way. A tool meant to catch what humans miss should not end up missing more in the patients who are already underserved.
What this means for you
If you’re a patient
If you’re having a root canal on an upper molar, the MB2 canal is a real thing worth asking about — but no app or algorithm is quietly finding it in your clinic yet. What actually matters is your dentist’s use of a dental microscope and, when needed, a CBCT scan. AI may become a helpful extra set of eyes; today it is not one you’re relying on.
If you’re a clinician
Treat these models as proof of concept, not products. The accuracy figures are real but come from home-turf datasets with unclear blinding and no external validation. If you trial a tool, demand evidence it was tested on outside data, and keep the final call — microscope, scan, and judgment — firmly yours.
The bottom line
AI can already spot, in a controlled test, the canal that dentists have missed for a century. That is worth celebrating. But spotting it once on your own dataset is a long way from earning a place in the operatory. The most useful thing this review does is refuse to confuse the two. For now, AI MB2 canal detection is a sharp assistant learning its trade — not an oracle, and certainly not the one holding the file.
Frequently asked questions
What is the MB2 canal, and why does it matter?
The MB2 (second mesiobuccal) canal is a narrow, often curved canal in the largest root of upper molars. It is present in roughly 69–93% of upper first molars but is easily overlooked during root canal treatment. A missed MB2 canal leaves infected tissue behind, which is a common reason root canals fail and need to be redone.
Can AI reliably find the MB2 canal now?
In laboratory tests, yes — AI models reached F1 scores up to 0.93 and above-0.80 sensitivity and accuracy on CBCT scans. But a 2026 scoping review found only five such studies, all still at the prototype stage, and none tested on outside data. So the performance is promising but not yet proven for everyday clinical use.
Does this mean AI will replace my endodontist?
No. Even the researchers describe these tools as decision-support adjuncts, not replacements. Finding a hidden canal is only one step in a root canal, and the accountability, judgment, and hands-on treatment stay with the dentist. AI is best understood as a second opinion that never gets tired, not a substitute for the clinician.
Is this AI available in dental clinics today?
Not in any validated, routine form. On a 9-level readiness scale, every model in the review sat at level 4 (prototype), with none reaching external validation, real-world testing, or regulatory approval. Any tool marketed for this should be asked, pointedly, for evidence it was tested beyond the dataset it was built on.
What would make it clinic-ready?
Three things the review keeps returning to: external, multi-center validation on diverse populations; transparent reporting so results can be reproduced; and regulatory clearance as a medical device. Until those exist, high accuracy alone doesn’t equal readiness.
Source & author credit
This article interprets, and does not reproduce, the following peer-reviewed study. All figures are the authors’ original findings.
Shaiban AS, Alobaid MA, Alqahtani OS, Alroomy R, Jabali A, Almnea RA, Alaajam WH, Mehta V, AlMoaleem MM. Clinical Readiness of Artificial Intelligence Models for MB2 Canal Detection in Maxillary Molars: A Scoping Review. International Dental Journal. 2026;76(5):109758. DOI: 10.1016/j.identj.2026.109758
ORCID — Riyadh Alroomy: 0000-0002-1117-1855; Ahmad Jabali: 0000-0001-6503-9334
Published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND 4.0) license. Decadentry is an independent educational publication and is not affiliated with the study’s authors. This article was written and fact-checked against the primary source per our editorial standards. Related reading: AI vs. Endodontist: Who Reads a Dental X-Ray Better?
Leave a Reply